Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shelden Martin

Sports Medicine Chandler, AZ Medical Doctor

NPI 1083878615 CMS profile 48644

525 S Chandler Village Dr, Chandler, AZ 85226

Open in the dashboard

General payments

$208,328

251 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shelden Martin of Chandler, AZ is reported in the CMS Open Payments database as having received $208,328 across 251 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,418 14
2024 General $20,190 14
2023 General $12,305 4
2022 General $25,511 45
2021 General $21,243 35
2020 General $63,231 66
2019 General $60,429 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shelden Martin
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Shelden Martin were reported at $5,418. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Shelden Martin Sports Medicine median Middle half National median
2019 $60,429 $1,176 $199–$4,249 $163
2020 $63,231 $708 $96–$2,890 $114
2021 $21,243 $1,213 $152–$3,994 $132
2022 $25,511 $1,230 $159–$3,998 $149
2023 $12,305 $584 $146–$2,836 $160
2024 $20,190 $628 $163–$3,168 $164
2025 $5,418 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TechMah Medical, LLC $70,710 52 payments
  2. Lima USA, Inc. $56,711 69 payments
  3. Zimmer Biomet Holdings, Inc. $53,319 74 payments
  4. Encore Medical, LP $20,643 13 payments
  5. FX Shoulder USA, Inc $4,589 2 payments
  6. ImpactOrtho, Inc. $1,241 3 payments
  7. Arthrex, Inc. $485 12 payments
  8. Smith+Nephew, Inc. $202 4 payments
  9. Anika Therapeutics, Inc. $145 1 payment
  10. DePuy Synthes Sales Inc. $103 5 payments
  11. Other $181 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $184,110 80 payments
  2. Travel and Lodging $17,666 73 payments
  3. Food and Beverage $4,995 96 payments
  4. Education $1,200 1 payment
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $357 1 payment
Products named General payments · program years 2019–2025
  1. SmartSpace Shoulder $56,581 31 payments
  2. Comprehensive Anatomic Extremities $36,025 26 payments
  3. Comprehensive Reverse $33,150 24 payments
  4. SMR $28,275 47 payments
  5. Signature Glenoid Guides $20,001 17 payments
  6. SMR Shoulder Devices $16,152 19 payments
  7. Smart SPACE $12,754 20 payments
  8. SMR SHOULDER Smr $11,256 2 payments
  9. AS 2.0 $11,024 5 payments
  10. Comprehensive Anatomic Extremities $5,047 5 payments
  11. Other $16,564 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

1,181

Median for Orthopedic Surgery: 203

Drug cost

$12,540

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 874 $10,005
Gabapentin Generic 157 $1,706
Celecoxib Generic 35 $418
Tramadol Hcl Generic 44 $139
Methylprednisolone Generic 13 $98
Cephalexin Generic 12 $84
Amoxicillin Generic 24 $52
Meloxicam Generic 22 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$166,559

Of which drugs: $14,713

Medicare patients

520

Average age 74

Services billed

2,063

284 women, 236 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 69%
Ischemic heart disease 29%
Depression 23%
Diabetes 21%
Chronic kidney disease 19%
Cancer 15%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 17 22 $12,184
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 190 479 $2,509

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

251 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record